Dietary sugar intervention: A promising approach for cancer therapy

Xinyi Zhou1, Yujia Song1, Zhen Wang1

  • 1Department of Liver Surgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, China; Laboratory of Liver Surgery, West China Hospital, Sichuan University, Chengdu, China.

Insights

Dietary sugars like glucose, fructose, and mannose significantly impact cancer progression through various mechanisms. Understanding these effects can lead to personalized dietary interventions for cancer patients.

Area of Science:

  • Oncology
  • Metabolic Research
  • Nutritional Science

Background:

  • Altered cellular metabolism is a key characteristic of cancer.
  • Diet influences tumor progression by modulating metabolites, signaling pathways, and the tumor microenvironment.
  • Gut microbiota and its metabolic activity are also affected by diet, influencing cancer development.

Purpose of the Study:

  • To explore the impact and mechanisms of dietary sugars (glucose, fructose, mannose) on tumors.
  • To investigate potential dietary interventions targeting sugar metabolism in cancer.
  • To summarize current clinical applications of these dietary interventions for personalized cancer treatment.

Main Methods:

  • Review of existing literature on dietary sugars and cancer.
  • Analysis of proposed mechanisms of action for dietary sugars on tumor cells and the tumor microenvironment.
  • Synthesis of clinical applications and potential for personalized dietary plans.

Main Results:

  • Dietary sugars directly influence cancer cell proliferation and apoptosis via signaling pathways.
  • Sugars indirectly affect tumors by altering nutrient availability and immune cell function.
  • Changes in gut microbiota composition and activity due to diet play a role in tumor development.

Conclusions:

  • Dietary sugars are critical modulators of cancer progression through direct and indirect mechanisms.
  • Targeting dietary sugar intake presents a promising avenue for novel cancer interventions.
  • Personalized dietary strategies hold potential for improving cancer treatment outcomes.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K